Public Health | December 11, 2021
Cipla aims to improve access to nebulisers in PHCs
The company will donate 5000 nebulizers to primary health care centres in rural India
The company will donate 5000 nebulizers to primary health care centres in rural India
The interim results of Phase 3 clinical trials conducted by CanSinoBIO demonstrated that Convidecia has an efficacy of 95.47% at preventing severe disease 14 days after single-dose vaccination.
Investment in single-use endoscopes, digital solutions, and endoluminal therapies expected
_256_384.jpg)
Ind-Ra expects IPM revenue growth of over 12% yoy for FY22.
The Institute of Pulmonology Medical Research & Development organised a symposium on early management of Covid-19
The combination rapid antigen test quickly differentiates between SARS-CoV-2 and influenza viruses A and B infections, with results ready in less than 30 minutes, allowing informed decisions on patient and pandemic management decisions
Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively
Soft-mist inhalation (SMI) technology allows for delivery of inhalation drugs from a small, portable hand-held inhaler device without the use of propellants
Rad-G is a rugged, portable, handheld Masimo SET Measure-through Motion and Low Perfusion pulse oximeter and noninvasive respiration rate monitor
_256_384.jpg)
India registers 18% of deaths annually due to air pollution while seven million die annually across the world due to air pollution
Subscribe To Our Newsletter & Stay Updated
